For RasWriter only
STUDY PROTOCOL Open Access
Effectiveness of Chinese massage therapy (Tui Na) for chronic low back pain: study protocol for a randomized controlled trial Mingxiao Yang1†, Yue Feng1†, Hong Pei2, Shufang Deng1, Minyu Wang1, Xianjun Xiao1, Hui Zheng1, Zhenhong Lai1, Jiao Chen1, Xiang Li1, Xiaoguo He2* and Fanrong Liang1*
Abstract
Background: Low back pain is a common, disabling musculoskeletal disorder in both developing and developed countries. Although often recommended, the potential efficacy of massage therapy in general, and Chinese massage (tuina) in particular, for relief of chronic low back pain (CLBP) has not been fully established due to inadequate sample sizes, low methodological quality, and subclinical dosing regimens of trials to date. Thus, the purpose of this randomized controlled trial (RCT) is to evaluate the comparative effectiveness of tuina massage therapy versus conventional analgesics for CLBP.
Methods/Design: The present study is a single center, two-arm, open-label RCT. A total of 150 eligible CLBP patients will be randomly assigned to either a tuina treatment group or a conventional drug control group in a 1:1 ratio. Patients in the tuina group receive a 20 minutes, 4-step treatment protocol which includes both structural and relaxation massage, administered in 20 sessions over a period of 4 weeks. Patients in the conventional drug control group are instructed to take a specific daily dose of ibuprofen. The primary outcome measure is the change from baseline back pain and function, measured by Roland-Morris Disability Questionnaire, at two months. Secondary outcome measures include the visual analogue scale, Japanese orthopedic association score (JOAS), and McGill pain questionnaire.
Discussion: The design and methodological rigor of this trial will allow for collection of valuable data to evaluate the efficacy of a specific tuina protocol for treating CLBP. This trial will therefore contribute to providing a solid foundation for clinical treatment of CLBP, as well as future research in massage therapy.
Trial registration: This trial was registered with ClinicalTrials.gov of the National Institute of Health on 22 October 2013 (NCT01973010).
Keywords: Chronic low back pain, Effectiveness, Randomized controlled trial, Tuina, Chinese massage therapy
Background Low back pain is a common, disabling musculoskeletal disorder in both developing and developed countries [1], with chronic low back pain (CLBP) being the leading cause of disability and absenteeism, worldwide [2]. The lifetime prevalence of low back pain in the general popu- lation is estimated to be between 70 and 85%, with an annual incidence rate ranging from 6.3 to 15.4% [1,3].
According to the 2000 UK guidelines, 90% of episodes of acute low back pain resolve spontaneously, with patients returning to work within a month [4,5]. However, several studies claim that low back pain and related loss of func- tion persist for 3 to 12 months [6,7] with more than 25% of patients experiencing recurrence of low back pain within a year [8]. Up to 7% of patients develop CLBP [9]. Because CLBP is not life-threatening, its enormous social and economic cost is often underestimated. As of 2010, the global burden of CLBP was reported to be comparable to that of cardiovascular disease, infectious disease, and cancer [10-12].
* Correspondence: [email protected]; [email protected] †Equal contributors 2Tuina Massage Department, The Fifth Hospital of Sichuan Province, No. 66, Shangye District, Chengdu, Sichuan 610031, China 1Chengdu University of Traditional Chinese Medicine, No.37, Shierqiao Road, Jinniu District, Chengdu, Sichuan 610072, China
TRIALS
© 2014 Yang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yang et al. Trials 2014, 15:418 http://www.trialsjournal.com/content/15/1/418
The pathophysiology of CLBP is poorly understood due to difficulties in localizing the source of the pain [13]. Potential causes of low back pain include, but are not limited to, changes in the spinal disc structure with aging and degeneration, as well as changes in local con- centrations of cytokines such as matrix metalloprotein- ases, phospholipase A2, nitric oxide, and tumor necrosis factor-α [14]. Based on data from the Low Back Pain Group of the Bone and Joint Health Strategies for Europe Project, most cases of low back pain are non-specific, with a specific cause being identified in only 10% of cases; non-specific low back pain is, by its definition, a symptom of unknown cause [15]. Specific conditions contributing to low back pain include degener- ation, inflammation, infective and neoplastic causes, meta- bolic bone diseases, referred pain, psychogenic pain, trauma, and congenital disorders [16]. In clinical practice, a focused medical history and
comprehensive physical examination are required for doctors to make appropriate treatment recommenda- tions. Diagnostic tests, including imaging studies such as X-ray, magnetic resonance imaging (MRI), and com- puted tomography (CT) are not routinely recommended for uncomplicated low back pain, except when severe or progressive deficits are present or when serious potential factors are suspected [17]. Conventional medications in several classes have been shown to have moderate short- term benefits for patients with low back pain. For most patients, first-line medication options include analgesics like acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) [18,19]. These medications have limited effectiveness and are frequently associated with undesir- able side-effects on gastrointestinal, renovascular, and other systems [20-22]. The heavy economic burden of low back pain has a huge impact on individuals, families, communities, governments, and businesses throughout the world. Thus, alternative back pain treatments are needed that minimize cost and maximize health benefit [23]. Although non-pharmacological treatments such as bed rest, exercise, acupuncture, massage, spinal manipu- lation, yoga, and cognitive behavioral therapy are com- monly prescribed in addition to pharmacologic therapy, the evidence supporting their efficacy is inconclusive. Chinese massage therapy (referred to as tuina) is
commonly defined as the ancient healing art of fingers and strength [24]. Tuina has been practiced in China for over 5000 years [25]. It is a well-respected treatment modality known to be helpful and safe for a wide range of conditions. For these reasons, it is rapidly gaining international favor [26]. Tuina involves a wide range of technical manipulations conducted by a practitioner’s finger, hand, elbow, knee, or foot applied to muscle or soft tissue at specific body locations. It incorporates many of the principles of acupuncture including the use
of acupoints. For instance, tuina often uses manual techniques such as pushing, rubbing, kneading, or high-intensity, high-frequency patting to clear energy blocks along specific meridians associated with par- ticular conditions [24]. At present, Chinese massage therapy is widely accepted
as a complementary and alternative medicine modality [27]. Its efficacy has been demonstrated for the manage- ment of many medical and psychiatric conditions. These include, but are not limited to, failure to thrive in preterm infants, major depressive disorder, substance abuse and dependence, pain syndromes, and immune and autoimmune conditions [28-31]. Massage therapy has been shown to be particularly effective for disorders of musculoskeletal origin [32]. However, due to a paucity of high-quality studies, there remains controversy about the efficacy and effectiveness of massage. Many clinical trials suffer from inadequate sample size, low methodological quality, and/or sub-therapeutic massage dosing [33]. As a result, the findings of recent systematic reviews about massage therapy for low back pain are consistently incon- clusive, due to the methodology flaws in the primary stud- ies they reference. Therefore, studies without these flaws are important to confirm the efficacy and effectiveness of tuina for low back pain [32,34]. This trial will therefore contribute to providing a solid foundation for clinical treatment of CLBP, as well as future research in massage therapy.
Methods/Design Ethics approval All trial procedures place the participant’s benefit as the highest priority. The present study protocol has already been ethically reviewed and approved by the Sichuan Regional Ethics Review Committee on Traditional Chinese Medicine (TCM) with the ethical approval identifier 2013KL-002.
Study design The present study is a single center, two-arm, open-label randomized controlled trial. All trial procedures will be conducted in the Fifth Hospital of Sichuan Province, Chengdu, China. A total of 150 eligible CLBP patients will be randomly assigned to either a tuina treatment group or a conventional drug control group in a 1:1 ratio (Figure 1).
Participants Eligible participants include patients diagnosed with CLBP according to the clinical guideline for traditional Chinese medicine (the Criteria of Diagnosis and Thera- peutic Effect of Diseases and Syndromes in Traditional Chinese Medicine, ZY/T001.1-94) [35]. Patients present- ing for the first time to either the Neurology Department
Yang et al. Trials 2014, 15:418 Page 2 of 7 http://www.trialsjournal.com/content/15/1/418
or the Tuina Department in the hospital for low back pain for over three months (without relief for over two weeks) will be informed of this trial. If the patient expresses inter- est, a clinical trial communicator will contact them to provide a brief introduction about the trial. Detailed infor- mation regarding patients’ low back pain will be acquired for further assessment of inclusion eligibility according to the following criteria.
Inclusion criteria In order to be included in this trial, participants have to be: (i) diagnosed with CLBP according to the aforemen- tioned diagnostic methods; (ii) between 20 to 55-year- old; (iii) free of immune dysfunction, genetic disorders, or severe cardiovascular diseases; (iv) free from prolapse
of the central lumbar intervertebral disc, ankylosing spondylitis, spinal stenosis, intraspinal tumor, and tuber- culosis; (v) free from any kind of hormonal or anti- rheumatic drugs for the two months prior to inclusion; (vi) free from allergies to hormones or analgesics; and (vii) able to understand and accept all trial procedures and cooperate with clinical physicians’ practices.
Exclusion criteria Participants with any one of the following conditions will be excluded from this trial: (i) pregnancy; (ii) severe heart, liver, or renal dysfunction; (iii) tumor; (iv) any hematological, respiratory, or cardiovascular disease; (v) any psychiatric disorder; (vi) severe nervous dysfunction resulting from vertebral pulp prolapse, (vii) cauda equina
Randomization
Screening
Data collection and statistical analysis
Effectiveness
Baseline assessment
Eligible Chronic Low Back Pain patients
Assessed by Clinical Center
Excluded Ineligible
Tuina massage group (N=75) (N=75)Conventional drug group
Treatment: 20 sessions in 4 weeks ITT analysis Dropout
Post-treatment assessment and follow ups
Safety Health economics
Figure 1 Trial flow chart. The present study is a single center, randomized, conventional drug controlled, open-labeled trial. A total of 150 eligible CLBP patients are anticipated to be included and randomly allocated to either tuina massage treatment group or conventional drug control group, in a 1:1 ratio. Patients in the tuina group receive a four-step massage treatment consisting both structural and relaxation massage. Tuina massage treatment consists of 20 sessions of approximately 20 minutes duration, each administered over a period of four weeks. Patients in the conventional drug control group are instructed to administer ibuprofen. The effectiveness, safety, and health economics of tuina massage versus conventional drugs is analyzed after data collection. The full analysis set including the dropout will be analyzed by the intention-to-treat (ITT) population analysis.
Yang et al. Trials 2014, 15:418 Page 3 of 7 http://www.trialsjournal.com/content/15/1/418
compression or other indications for spinal surgery; (viii) sciatica, (ix) lumbar surgery within the past three years; (x) any disorders that may confound the assessment of tuina efficacy, such as severe fibromyalgia or rheumatic arthritis; (xi) ongoing corticosteroid or NSAID use, (xii) history of allergy to NSAIDs; and (xiii) have received tuina therapy for CLBP in the past three months. Benefits and risks are clearly explained to eligible pa-
tients before inclusion. Prior to trial inclusion, all eligible patients will provide their written consent.
Randomization In this trial, participants will be randomly assigned to either the tuina group or the ibuprofen group in a 1:1 ratio using a random number generator (SPSS 16.0, SPSS Inc, Chicago, IL, USA).
Blinding As an open-label clinical trial, both patients and clini- cians know which treatment approach they will receive, and they are required to cooperate with their physicians or therapists prior to treatment. The assessment of clin- ical efficacy will be performed over the telephone by a clinical assessor who will be masked to the treatment as- signment. During the data collection and analysis stages, the clinical researcher, assessor, and statistician do not share study information with each other.
Interventions The tuina protocol used in this trial is the same as those used in our previous studies [36,37]. It includes both re- laxation methods and structural methods such as rolling, pressing, jostling, friction, pulling, and tapping.
Tuina treatment group The CLBP patient will receive tuina massage therapy for 20 minutes, five times a week for a total of four weeks. Lumbar function will be assessed at baseline as well as at four, six, and eight weeks after the baseline assessment. In this arm of the study, the tuina therapist will
administer a four-step protocol intended to ease low back pain and improve lumbar function by promoting Qi movement (which according to traditional Chinese medi- cine theory activates blood circulation), or by inducing a state of general relaxation sensation while addressing specific structural issues determined by the clinician to be likely to contribute to the patient’s CLBP. The specific protocol used is described below.
Step one: relaxation manipulation Patients are instructed by the tuina therapist to lie in the prone position and to relax their mind and body. Low back pain conditions can be carefully examined by postural and palpatory assessment prior to treatment. Tender
tissues, trigger points, contracted muscle tissue (knots), and nodules are identified for further treatment. The ther- apist will use his forearm to gently roll on the low back area from the bilateral erector spinae muscles to both thighs, and then continuously from the low back to the gastrocnemius muscle through to the buttocks, for a total of five minutes. During this time, the force and pressure are gradually increased with the intention of smoothing the Qi pathways to promote Qi movement in different physiological layers. Then, the therapist will apply mild force and pressure with overlapped palms to the lumbosa- cral area and lower limbs for five minutes, moving infer- iorly and concluding with the gastrocnemius muscle. This technique will be performed to resolve adhesions and increase general circulation.
Step two: local pressing pain point manipulation The pressing pain point, or namely A-Shi point in acupunc- ture theory, is the tender local dermal or muscular area. It is generally recognized as reflecting the underlying condition and is frequently manipulated to stop pain. In this step, the therapist will apply muscle pressing, strip- ping, and deep tissue kneading to the pressing pain point in the lumbar region in a direction perpendicular to the erector spinae. The pressure and amplitude shall be gradually intensified and enlarged throughout the five-minute manipulation, which is intended to unblock Qi stagnation, remove blood stasis by separating adher- ent fascicles, and resolve contracted nodules of muscle. The amount of force used is determined by the patient’s Deqi sensation, often described as a dull pain, heaviness, numbness, or soreness, and commonly regarded as an indicator of manipulation effectiveness in acupuncture and tuina [38-40].
Step three: lumbar structural rectification Lumbar structural rectification is performed after the above two procedures have relieved the tensions of muscles and soft tissues. The patient will be instructed to lie on his or her side (with the affected side up). The affected leg is slightly flexed at the hip and knee in a relaxed pos- ition, while the other leg is naturally extended on the massage table. The therapist stands facing the patient with two hands joined and elbows bent. One of the therapist’s elbows will be fixed on the anterior aspect of the patient’s shoulder, while the other will be placed in the posterior-lateral aspect of the patient’s iliac bone, in the gluteal area of the external hip rotators. First, the therapist can exert a gentle torque to align
the patient’s lower back and perform a slight shake to relax the area. Second, the therapist will push down (toward the table) and stretch the patient’s shoulder anteriorly while stretching the hips posteriorly, rotating the lumbar vertebra along the spinal axis to release the
Yang et al. Trials 2014, 15:418 Page 4 of 7 http://www.trialsjournal.com/content/15/1/418
fixing points instantly. After the lumbar muscles are suf- ficiently relaxed by gentle tractions and twisting forces, the therapist can twist the lumbar muscles slightly fur- ther to remove any remaining slack in them. The therap- ist shall hold this position for a moment and then made an abrupt pulling motion to advance the stretch by 5 to 10 degrees.
Step four: tapping manipulation The therapist use his or her palm to tap the lumbosacral area for two minutes to generate a warm sensation in deep tissue, and then rub the area superficial to the back pain, as well as the bilateral lines of the urinary bladder meridian.
Conventional control group Patients in the control group will receive a conventional pharmacological treatment regimen of one 0.3 g capsule of sustained-release ibuprofen, taken three times each day (Ibuprofen Sustained Release Capsules, 0.3 g per capsule, Sino-GlaxoSmithKline, Tianjin, China).
Study therapists All practitioners in this trial are licensed TCM tuina therapists with at least five years clinical experience in the hospital’s Tuina Department. Before taking part in this trial, they will be required to complete a 40-hour
training course to master the study protocol. When completed, clinicians will be required to pass an examin- ation during which they are asked to recite the protocol verbally and provide a demonstration of each technique.
Outcome measurements The efficacy of massage therapy for the treatment of CLBP is assessed by the primary outcome measure: change in back pain and function from baseline as mea- sured by the Roland-Morris Disability Questionnaire at four time points (baseline, four, six, and eight weeks). Secondary outcome measures also measured at these four time points included the (i) 100-point visual analog scale (VAS), (ii) Japanese Orthopedic Association Score to assess the improvement of back function, and (iii) McGill pain questionnaire to assess the alleviation of pain. Table 1 demonstrates all measurements and meas- uring time points.
Safety Therapeutic safety will be monitored by assessment of patient symptoms as well as blood, urine, and stool tests conducted pre- and post-treatment. Adverse events such as changes in pain, syncope, vertigo, and lumbar func- tion degradation, will be carefully recorded in the case report form.
Table 1 Trial process chart
Period Inclusion Treatment Follow-up
Assessment Baseline First Second Third
Measure point 0 weeks after inclusion 4 weeks after inclusion 6 weeks after inclusion 8 weeks after inclusion
Diagnosis and treatment
Inclusion confirmed √
Informed consent √
Body sign √ √
Disease history √
Treatment history √
Comorbidity √ √ √ √
Current treatment √ √ √ √
Pain condition and lumbar function assessment
Visual Analogue Scale √ √ √ √
Roland-Morris Disability Questionnaire √ √ √ √
McGill pain questionnaire √ √ √ √
Japanese Orthopedic Association Score √ √ √ √
Data collection and statistical analysis
Adverse event √
Causes of dropout √ √ √
Safety analysis √
Compliance analysis √ √ √
Health economics √
Yang et al. Trials 2014, 15:418 Page 5 of 7 http://www.trialsjournal.com/content/15/1/418
Health economics All costs associated with this trial will be recorded. They primarily include the medical costs for direct treatment of the CLBP, such as inpatient bed fees, medication fees, massage treatment fees, usual care, and testing fees. Additionally, any cost of treatment for adverse events will be recorded and included in the health economics evaluation.
Sample size calculation Sample size was calculated by G*Power 3 software, de- veloped by the Institute for Experimental Psychology (Heinrich-Heine University, Germany). For this trial, it was determined prospectively that α =0.05 and 1-β =0.90. Consistent with a previous trial on massage for lumbar disc herniation [41], a total of 150 participants will be in- cluded in this trial (75 in each group) to compensate for an anticipated dropout rate of 15%.
Data analysis Demographic and baseline data will be analyzed with standard, descriptive statistics. Between-group differ- ences will be tested using repeated measure analyses of variance. The accepted level of significance for all ana- lyses was P <0.05. The whole data analysis process will be performed by statisticians who are independent from the research team and blinded to the group settings. SPSS software (SPSS 12.0 KO for Microsoft Windows® SPSS, Inc., Chicago, IL, USA ) was used to perform the data analysis.
Discussion The present trial is a comparative effectiveness study of TCM tuina massage and conventional analgesics for pain relief and function recovery in patients with CLBP. The massage techniques used in this trial combine relax- ation and structural massage methods applied in a man- ner which is consistent with TCM theory and is based on recognition of the same energetic meridians and acu- points used in acupuncture. According to TCM, a state of health reflects an under-
lying state of balance in the Qi and blood of the human body. Pain is usually caused by obstruction of Qi and consequently of blood circulation in the affected body region. Pathogenic factors such as blood stasis, Qi stag- nation, phlegm, dampness, and others can be identified as causative factors in the blockage. Thus, the central therapeutic goal of tuina is to remove energetic blocks which lead to Qi stagnation. This leads to increased cir- culation and reduction of localized edema, which helps to reduce associated pain. The A-Shi point in TCM is the site on the body sur-
face which reproduces the specific pain being treated when it is gently pressed. Its location indicates the
precise place where Qi and blood are blocked. Manipula- tion at the A-Shi point is done with the intention of re- moving the energetic block there to promote the free movement of Qi and improve blood circulation in the region. Studies have demonstrated that one mechanism by which massage therapy appears to be clinically beneficial is by reducing inflammation and promoting mitochondrial biogenesis for repair of damaged skeletal muscle [42]. A recent trial reported no clinically meaningful differ-
ence in the effectiveness of structural and relaxation massage [43]. In contrast, this trial compares the efficacy of a specific form of massage based on the principles of TCM (tuina) with conventional analgesics (ibuprofen) for pain relief and functional recovery in patients with CLBP. Each of these types of massage is done with very different intentions underlying theoretical frameworks. Therefore, it is important to develop a degree of specifi- city in referring to a type of massage, both in research and in prescribing clinical massage for a particular con- dition. There is no placebo control in this trial because of the difficulties in designing a proper placebo for mas- sage therapy which have been described by others [44]. A possible limitation of this study is that it may possibly be difficult to maintain high compliance in follow-up, due to the long interval since the completion of trial. Proper actions, such as frequent telephone interview, will be taken to improve compliance. The design and methodological rigor of this trial will
allow for collection of valuable, high-quality data to evaluate the efficacy of a specific tuina protocol for treating CLBP, and so will contribute to providing a solid foundation for the clinical treatment of CLBP, as well as future research in massage therapy.
Trial status This trial is recruiting patients now. Participant recruit- ment started in June 2013, and is expected to end in December 2014.
Abbreviations CLBP: Chronic Low Back Pain; CT: Computed tomography; JOAS: Japanese Orthopedic Association Score; MRI: Magnetic resonance imaging; NSAIDs: Nonsteroidal anti-inflammatory drugs; TCM: Traditional Chinese Medicine; VAS: Visual Analogue Scale; ITT: Intention-to-Treat.
Competing interests The authors declare that they have no competing interests.
Authors’ contributions FRL conceived of the study, and participated in its design. MXY participated in the design of the study and coordination and drafted the manuscript. XGH carried out the massage treatments for patients. YF participated in the design of the study. HP recruited patients from inpatient department and performed massage treatment. SFD interviewed patients before and after treatment and collected clinical data. MYW recruited and screened eligible participants from outpatient department. XJX assigned patients to either massage group or control group. HZ participated in the design of the study and performed the statistical analysis. ZHL participated in trial design and
Yang et al. Trials 2014, 15:418 Page 6 of 7 http://www.trialsjournal.com/content/15/1/418
helped to prepare the manuscript. JC assessed treatment effectiveness and collected clinical data. XL recruited patients from outpatient department. All authors read and approved the final manuscript.
Acknowledgments We thank Dr Kristin Jerger from Duke Integrative Medicine (Duke University, Durham, North Carolina, United States) for her constructive suggestions and tremendous help in manuscript revision. We also thank Dr Jie Yang from Chengdu University of Traditional Chinese Medicine for her suggestions in trial design and guidance in trial implementation. This trial was financially supported by funds from the Science and Technology Department of Sichuan province (grant number 2011SZ0302), and funds from the National Scientific Foundation Committee (grant number 81102662).
Received: 20 June 2014 Accepted: 15 October 2014 Published: 29 October 2014
References 1. Hoy D, Brooks P, Blyth F, Buchbinder R: The epidemiology of low back
pain. Best Pract Res Clin Rheumatol 2010, 24:769–781. 2. Lidgren L: The bone and joint decade 2000–2010. Bull World Health Organ
2003, 81:629–629. 3. Andersson GB: Epidemiological features of chronic low-back pain. Lancet
1999, 354:581–585. 4. Koes BW, van Tulder MW, Ostelo R, Burton AK, Waddell G: Clinical
guidelines for the management of low back pain in primary care: an international comparison. Spine 2001, 26:2504–2513.
5. Waddell G, Burton AK: Occupational health guidelines for the management of low back pain at work: evidence review. Occup Med 2001, 51:124–135.
6. Croft PR, Macfarlane GJ, Papageorgiou AC, Thomas E, Silman AJ: Outcome of low back pain in general practice: a prospective study. BMJ 1998, 316:1356.
7. Pengel LH, Herbert RD, Maher CG, Refshauge KM: Acute low back pain: systematic review of its prognosis. BMJ 2003, 327:323.
8. Stanton TR, Henschke N, Maher CG, Refshauge KM, Latimer J, McAuley JH: After an episode of acute low back pain, recurrence is unpredictable and not as common as previously thought. Spine 2008, 33:2923–2928.
9. Speed C: Low back pain. BMJ 2004, 328:1119–1121. 10. Dionne CE, Dunn KM, Croft PR: Does back pain prevalence really decrease
with increasing age? A systematic review. Age Ageing 2006, 35:229–234. 11. Hoy D, March L, Brooks P, Woolf A, Blyth F, Vos T, Buchbinder R: Measuring
the global burden of low back pain. Best Pract Res Clin Rheumatol 2010, 24:155–165.
12. Maetzel A, Li L: The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 2002, 16:23–30.
13. Jenner J, Barry M: ABC of rheumatology: low back pain. BMJ 1995, 310:929.
14. Biyani A, Andersson GB: Low back pain: pathophysiology and management. J Am Acad Orthop Surg 2004, 12:106–115.
15. Balagué F, Mannion AF, Pellisé F, Cedraschi C: Non-specific low back pain. Lancet 2012, 379:482–491.
16. Krismer M, Van Tulder M: Low back pain (non-specific). Best Pract Res Clin Rheumatol 2007, 21:77–91.
17. Goodman DM, Burke AE, Livingston EH: JAMA patient page: low back pain. JAMA 2013, 309:1738.
18. Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, Owens DK: Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147:478–491.
19. Mens J: The use of medication in low back pain. Best Pract Res Clin Rheumatol 2005, 19:609–621.
20. Hernandez-Diaz S, Rodriguez LAG: Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/ perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000, 160:2093.
21. van Tulder MW, Scholten RJ, Koes BW, Deyo RA: Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000, 25:2501–2513.
22. Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC: Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily. JAMA 2006, 296:87–93.
23. Maniadakis N, Gray A: The economic burden of back pain in the UK. Pain 2000, 84:95–103.
24. Goats GC: Massage–the scientific basis of an ancient art: Part 1: the techniques. Br J Sports Med 1994, 28:149–152.
25. Goats GC: Massage–the scientific basis of an ancient art: Part 2: physiological and therapeutic effects. Br J Sports Med 1994, 28:153–156.
26. Ernst E: The safety of massage therapy. Rheumatology 2003, 42:1101–1106. 27. Moyer CA, Rounds J, Hannum JW: A meta-analysis of massage therapy
research. Psychol Bull 2004, 130:3. 28. Field T: Massage therapy. Med Clin North Am 2002, 86:163. 29. Weinrich SP, Weinrich MC: The effect of massage on pain in cancer
patients. Appl Nurs Res 1990, 3:140–145. 30. Field T, Hemandez-Reif M, Taylor S, Quintino O, Burman I: Labor pain is reduced
by massage therapy. J Psychosom Obstet Gynaecol 1997, 18:286–291. 31. Field TM: Massage therapy effects. Am Psychol 1998, 53:1270. 32. Kumar S, Beaton K, Hughes T: The effectiveness of massage therapy for
the treatment of nonspecific low back pain: a systematic review of systematic reviews. Int J General Med 2013, 6:733.
33. Lewis M, Johnson MI: The clinical effectiveness of therapeutic massage for musculoskeletal pain: a systematic review. Physiotherapy 2006, 92:146–158.
34. Furlan AD, Imamura M, Dryden T, Irvin E: Massage for low-back pain. Cochrane Database Syst Rev 2008, CD001929: 1-104.
35. Xue CC, English R, Zhang JJ, Da Costa C, Li CG: Effect of acupuncture in the treatment of seasonal allergic rhinitis: a randomized controlled clinical trial. Am J Chinese Med 2002, 30:1–11.
36. Luo C, Wang F: Chinese Tuina Therapeutics. Beijing: People’s Medical Publishing House; 2003.
37. Luo C, Lv Z: A clinical resport of the effectiveness of massage therapy for 40 cases of chronic low back pain. Chin Manipulation Qi Gong Ther 1995, 6:7–8.
38. Hui KK, Nixon EE, Vangel MG, Liu J, Marina O, Napadow V, Hodge SM, Rosen BR, Makris N, Kennedy DN: Characterization of the “deqi” response in acupuncture. BMC Complement Altern Med 2007, 7:33.
39. Kong J, Gollub R, Huang T, Polich G, Napadow V, Hui K, Vangel M, Rosen B, Kaptchuk TJ: Acupuncture de qi, from qualitative history to quantitative measurement. J Altern Complement Med 2007, 13:1059–1070.
40. Shi G-X, Yang X-M, Liu C-Z, Wang L-P: Factors contributing to therapeutic effects evaluated in acupuncture clinical trials. Trials 2012, 13:1–5.
41. Huang K-Y, Xia H-M: Massage for treatment of lumbar disc herniation in 371 cases of efficacy. J Clin Acupunct Moxibustion 2010, 3:019.
42. Crane JD, Ogborn DI, Cupido C, Melov S, Hubbard A, Bourgeois JM, Tarnopolsky MA: Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. Sci Transl Med 2012, 4:3002882.
43. Cherkin DC, Sherman KJ, Kahn J, Wellman R, Cook AJ, Johnson E, Erro J, Delaney K, Deyo RA: A comparison of the effects of 2 types of massage and usual care on chronic low back pain: a randomized, controlled trial. Ann Intern Med 2011, 155:1–9.
44. Machado L, Kamper S, Herbert R, Maher C, McAuley J: Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials. Rheumatology 2009, 48:520–527.
doi:10.1186/1745-6215-15-418 Cite this article as: Yang et al.: Effectiveness of Chinese massage therapy (Tui Na) for chronic low back pain: study protocol for a randomized controlled trial. Trials 2014 15:418.
Yang et al. Trials 2014, 15:418 Page 7 of 7 http://www.trialsjournal.com/content/15/1/418
BioMed Central publishes under the Creative Commons Attribution License (CCAL). Under the CCAL, authors retain copyright to the article but users are allowed to download, reprint, distribute and /or copy articles in BioMed Central journals, as long as the original work is properly cited.
- Abstract
- Background
- Methods/Design
- Discussion
- Trial registration
- Background
- Methods/Design
- Ethics approval
- Study design
- Participants
- Inclusion criteria
- Exclusion criteria
- Randomization
- Blinding
- Interventions
- Tuina treatment group
- Conventional control group
- Study therapists
- Outcome measurements
- Safety
- Health economics
- Sample size calculation
- Data analysis
- Discussion
- Trial status
- Abbreviations
- Competing interests
- Authors’ contributions
- Acknowledgments
- References